Citryll
Patrick Round graduated as a physician from Charing Cross Hospital Medical School in 1982. He has 30 years experience in the pharmaceutical industry starting at Novo Nordisk and Glaxo Wellcome; was Chief Medical Officer at Celltech, Cambridge Antibody Technology and Xention.
Over the past 12 years he has taken the role of Chief Medical Officer at a number of biotech start-up companies across a wide range of therapeutic areas including BVG portfolio companies Dezima and NorthSea Therapeutics. He is currently also consulting for Staten Biotechnology.
This person is not in any offices